2024-03-28T14:52:25Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_75C6C1BEBB64
2024-03-23T02:32:38Z
serval:BIB_75C6C1BEBB64
An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for Human Epidermal Growth Factor Receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.
10.1016/j.ejca.2012.08.006
22999386
000313193000001
Bonnefoi
H.
author
Zaman
K.
author
Debled
M.
author
Fiche
M.
author
Fournier
M.
author
Nobahar
M.
author
Pierga
J.Y.
author
Koch
K.M.
author
Bartlett
J.
author
Zimmer
A.
author
Marreaud
S.
author
Bogaerts
J.
author
Cameron
D.
author
article
2013
European Journal of Cancer
1879-0852
0959-8049
journal
49
2
281-289
eng
60_published
peer-reviewed
Publication types: Journal Article